Altman's Vast Investment Portfolio
Sam Altman's personal wealth is dispersed across a sprawling network of technology companies, ranging from nuclear fusion to biotech, software, and energy. In 2023, he publicly stated that he had invested in approximately 400 startups. The Wall Street Journal identified over 80 of these projects from public records, many dating back to his tenure at Y Combinator. Notably, Altman holds no direct equity in OpenAI, which is valued at $852 billion, meaning his personal interests are not directly tied to the company he leads.
Among his investments, at least 10 companies have established commercial partnerships with OpenAI or recently negotiated such deals. OpenAI has formed research collaborations with two biotech companies in which Altman personally invested. Retro Biosciences, an anti-aging startup, saw Altman's stake valued at $258 million as of December 2025. Chipmaker Cerebras, in which Altman invested nearly a decade ago, secured a chip procurement agreement with OpenAI before its IPO, boosting Altman's holding value by more than six times.
Conflict of Interest and Internal Turmoil
CEOs of public companies are typically advised against holding large stakes in external firms, but OpenAI Board Chair Bret Taylor stated that Altman has been transparent about his outside engagements and that the company has managed potential conflicts carefully. Nevertheless, the U.S. House Oversight Committee launched an investigation in April 2026, and several state attorneys general have called for SEC intervention. During the trial of Elon Musk's lawsuit against OpenAI, former board member Shivon Zilis testified that the OpenAI-Helion deal was "surprising" given the speculative nature of nuclear fusion.
Altman's push for collaboration between OpenAI and Helion sparked significant internal controversy. After SoftBank invested in OpenAI in 2025, Altman lobbied SoftBank to also invest in Helion, which it did. He then urged OpenAI to invest approximately $500 million in Helion, a move that caused unease among some OpenAI employees. The company ultimately rejected the proposal. However, in March 2026, OpenAI signed a revised agreement with Helion, which the board deemed in the company's best interest.
The Helion Decade-Long Bond and Massive Returns
Altman's relationship with Helion began in 2015 when he invested and became chairman of its board, the same year he co-founded OpenAI. In 2021, while running OpenAI, he poured $375 million into Helion, his largest personal investment in a single startup at that time. In 2024, OpenAI signed a non-binding agreement to purchase electricity from Helion in the future. In March 2026, Altman resigned as Helion's chairman, citing his future collaboration with OpenAI. In June 2026, Helion raised a new round at a $15.5 billion valuation, with OpenAI strategic investor Thrive Capital participating. Altman's stake at least doubled to $4.1 billion.
Snowball Effect: Cerebras, Worldcoin, and Other Bets
Beyond Helion, Altman's portfolio includes Tools for Humanity, the developer of Worldcoin, which was valued at $2.5 billion. The company has recently faced internal investigations into executive fund misuse and regulatory violations in Thailand. OpenAI also signed massive contracts with Nvidia ($500 billion), AMD ($300 billion), Oracle ($300 billion), and CoreWeave (over $22 billion), amplifying Altman's influence. He also holds stakes in Stripe, Reddit, and other notable tech firms. According to Forbes, Altman's net worth stands at approximately $3.4 billion, ranking 1,251st globally—up from 2,692nd two years earlier, a surge of over 1,400 places.
